CEVA INC
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Interim Condensed Consolidated Financial Statements
| NOTE 1: | BUSINESS |
|---|
The financial information in this quarterly report includes the results of Ceva, Inc. and its subsidiaries (the “Company” or “Ceva”).
Ceva is the leader in innovative silicon and software intellectual property (“IP”) solutions that enable smart edge products to connect, sense, and infer data more reliably and efficiently. With a broad portfolio of comprehensive wireless communications and processor IP platforms and embedded software solutions for the deployment of artificial intelligence (“AI”) algorithms and models directly onto local edge devices (“Edge AI”), Ceva powers the connectivity, sensing, and inference capabilities in today’s most advanced smart edge products across consumer internet of things (“IoT”), automotive, industrial, infrastructure, mobile and personal computing (“PC”) markets. Since 2003, more than 19 billion of the world’s most innovative smart edge products from AI-infused smartwatches, IoT devices and wearables to autonomous vehicles, 5G mobile networks and more have been shipped with Ceva IP, with approximately 2 billion shipped in 2024 alone.
Ceva is a trusted partner to many of the leading semiconductor and original equipment manufacturer (“OEM”) companies servicing not just Ceva’s largest target growth and incumbent markets, but also a wide variety of other end markets and applications, including smart-home, surveillance, robotics and medical. Ceva’s customers incorporate Ceva’s IP into application-specific integrated circuits and application-specific standard products that they manufacture, market and sell.
Ceva’s wireless communications, sensing and edge AI technologies are at the heart of some of today’s most advanced smart edge products. Our comprehensive portfolio includes:
Advanced wireless connectivity solutions: Bluetooth, Wi-Fi, Ultra-Wideband, and 5G-Advanced platform IP for ubiquitous and robust communication;
Scalable edge AI capabilities: neural processing unit IP to enable AI, on-device; and
Sensor fusion processors, and embedded application software that make devices smarter and more responsive.
Ceva licenses its portfolio of wireless communications and scalable edge AI IP to its customers, breaking down barriers to entry and enabling them to bring new cutting-edge products to market faster, more reliably, efficiently and economically.
| NOTE 2: | BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
|---|
Basis of Presentation
The interim condensed consolidated financial statements have been prepared according to U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).
The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the year ending December 31, 2025. For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2024, contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2025, have been applied consistently in these unaudited interim condensed consolidated financial statements.
Concentration of credit risk:
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.
The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits may be redeemed on demand and therefore minimal credit risk exists with respect to them. Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents may be redeemed upon demand, and therefore management believes that they bear a lower risk. The short-term bank deposits are held in financial institutions that management believes are institutions with high credit standing and, accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. The Company has the ability to hold such investments until recovery of temporary declines in market value or maturity.
The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific region, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers. The Company makes estimates of expected credit losses based upon its assessment of various factors, including historical experience, the age of the trade receivable balances, credit quality of its customers, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect its ability to collect from customers.
As of March 31, 2025, the allowance for credit losses amounted to $2,626. During the three-month period ending on that date, the Company didnot record any further allowance for credit losses.
The Company has no off-balance-sheet concentration of credit risk.
Accounting Standards Recently Issued, Not Yet Adopted by the Company
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosure (Subtopic 220-40), Disaggregation of Income Statement Expenses, which requires disclosure of disaggregated information about certain expense captions presented in the Consolidated Statements of Operations as well as disclosure about selling expense. The guidance will be effective for the Company for annual periods beginning January 1, 2027 and interim periods beginning January 1, 2028, with early adoption permitted. It could be applied either prospectively or retrospectively. The Company is currently evaluating the impact on its financial statement disclosures.
Use of Estimates
The preparation of the interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
| NOTE 3: | ACQUISITION |
|---|
In January 2024, the Company acquired a privately held, Greece-based radio frequency design company (now operating under the name “Ceva Technologies Single Member Private Company”). Under the terms of the purchase agreement, the Company agreed to pay an aggregate of approximately $753 paid at closing and approximately $2,100 contingent on continued employment and certain performance milestones. During the first quarter of 2025, the Company paid $425 toward this contingent amount. The Company has accounted for the acquisition as an asset acquisition. As such, the total purchase consideration was allocated to the assets acquired.
| NOTE 4: | REVENUE RECOGNITION |
|---|
Under Accounting Standards Codification (“ASC”) No. 606, “Revenue from Contracts with Customers” (“ASC 606”), an entity recognizes revenue when or as it satisfies a performance obligation by transferring intellectual property (“IP”) licenses or services to the customer, either at a point in time or over time. The Company recognizes most of its revenues at a point in time upon delivery when the customer accepts control of the IP. The Company recognizes revenue over time on significant license customization contracts that are in the scope of ASC 606 by using cost inputs to measure progress toward completion of its performance obligations.
Revenues that are derived from the sale of a licensee’s products that incorporate the Company’s IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company’s IP occurs. Royalties are calculated either as a percentage of the revenues received by the Company’s licensees on sales of products incorporating the Company’s IP or on a per unit basis, as specified in the agreements with the licensees. When the Company does not receive actual sales data from the customer prior to the finalization of its financial statements, royalty revenues are recognized based on the Company’s estimation of the customer’s sales during the quarter.
The following table includes estimated revenue expected to be recognized in future periods related to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period. The estimated revenues do not include amounts of royalties or unexercised contract renewals:
| Remainder of 2025 | 2026 | 2027 and thereafter | |
|---|---|---|---|
| Licensing and related revenues | $10,793 | $3,119 | $93 |
Disaggregation of revenue:
The following table provides information about disaggregated revenue by primary geographical, use cases for the Company's technology portfolio, and timing of revenue recognition:
| Three months ended March 31, 2025 (unaudited) | Three months ended March 31, 2024 (unaudited) | |||||
|---|---|---|---|---|---|---|
| Licensing and related revenues | Royalties | Total | Licensing and related revenues | Royalties | Total | |
| Geography | ||||||
| United States | $2,415 | $1,204 | $3,619 | $383 | $2,155 | $2,538 |
| Europe and Middle East | 506 | 978 | 1,484 | 601 | 911 | 1,512 |
| Asia Pacific | 12,121 | 7,021 | 19,142 | 10,417 | 7,592 | 18,009 |
| Other | — | — | — | 13 | — | 13 |
| Total | $15,042 | $9,203 | $24,245 | $11,414 | $10,658 | $22,072 |
| Use cases for the Company’s technology portfolio | ||||||
| Connect (baseband for handset and other devices, Bluetooth, Wi-Fi and NB-IoT) | $13,513 | $6,932 | $20,445 | $10,067 | $7,939 | $18,006 |
| Sense & Infer (sensor fusion, audio, sound, imaging, vision and AI) | 1,529 | 2,271 | 3,800 | 1,347 | 2,719 | 4,066 |
| Total | $15,042 | $9,203 | $24,245 | $11,414 | $10,658 | $22,072 |
| Timing of revenue recognition | ||||||
| Products transferred at a point in time | $11,390 | $9,203 | $20,593 | $9,453 | $10,658 | $20,111 |
| Products and services transferred over time | 3,652 | — | 3,652 | 1,961 | — | 1,961 |
| Total | $15,042 | $9,203 | $24,245 | $11,414 | $10,658 | $22,072 |
Contract balances:
The following table provides information about trade receivables, unbilled receivables and contract liabilities from contracts with customers:
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| Currents assets (classified under “Trade receivables”): | ||
| Trade receivables | $15,088 | $15,969 |
| Unbilled receivables (associated with licensing and related revenue) | 17,274 | 8,266 |
| Unbilled receivables (associated with royalties) | 8,457 | 12,974 |
| Total current assets | 40,819 | 37,209 |
| Long-term assets (classified under “Other long-term assets”): | ||
| Unbilled receivables (associated with licensing and related revenue) | 2,668 | 2,583 |
| Deferred revenues (short-term contract liabilities) | 2,954 | 3,599 |
The Company receives payments from customers based upon contractual payment schedules; trade receivables are recorded when the right to consideration becomes unconditional, and an invoice is issued to the customer. Unbilled receivables associated with licensing and other include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Unbilled receivables associated with royalties are recorded as the Company recognizes revenues from royalties earned during the quarter, but not yet invoiced, either by actual sales data received from customers, or, when applicable, by the Company’s estimation. Contract liabilities (deferred revenue) include payments received in advance of performance under the contract and are realized with the associated revenue recognized under the contract.
During the three months ended March 31, 2025, the Company recognized $1,114 that was included in deferred revenues (short-term contract liability) balance at January 1, 2025.
| NOTE 5: | LEASES |
|---|
The Company leases substantially all of its office space and vehicles under operating leases. The Company's leases have original lease periods expiring between 2025 and 2034. Many leases include one or more options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain. Lease payments included in the measurement of the lease liability comprise the following: the fixed non-cancelable lease payments, payments for optional renewal periods where it is reasonably certain the renewal period will be exercised, and payments for early termination options unless it is reasonably certain the lease will not be terminated early.
The following is a summary of weighted average remaining lease terms and discount rates for all of the Company’s operating leases:
| March 31, 2025 (Unaudited) | |
|---|---|
| Weighted average remaining lease term (years) | 4.58 |
| Weighted average discount rates | 3.89% |
Total operating lease cost and cash payments for operating leases were as follows:
| Three months ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | (unaudited) | |
| Operating lease cost | $710 | $663 |
| Cash payments for operating leases | 989 | 622 |
Maturities of lease liabilities are as follows:
| The remainder of 2025 | $1,725 |
| 2026 | 1,082 |
| 2027 | 808 |
| 2028 | 445 |
| 2029 | 327 |
| 2030 and thereafter | 840 |
| Total undiscounted cash flows | 5,227 |
| Less imputed interest | 395 |
| Present value of lease liabilities | $4,832 |
During March 2025, the Company signed an operating lease agreement for new offices in Israel, resulting in an additional lease commitment of approximately $9,900. As of March 31, 2025, the lease has not yet commenced. The lease is expected to commence during 2025, and will remain in effect until December 30, 2035, with an option to extend the lease for an additional period of up to 5 years, subject to the conditions of the lease agreement.
| NOTE 6: | MARKETABLE SECURITIES |
|---|
The following is a summary of available-for-sale marketable securities:
| March 31, 2025 (Unaudited) | ||||
|---|---|---|---|---|
| Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | |
| Available-for-sale - matures within one year: | ||||
| Corporate bonds | $39,596 | $51 | $(310) | $39,337 |
| Available-for-sale - matures after one year through three years: | ||||
| Corporate bonds | 98,714 | 335 | (905) | 98,144 |
| Total | ||||
| $138,310 | $386 | $(1,215) | $137,481 | |
| Amortized cost | Gross unrealized gains | Gross unrealized losses | Fair value | |
|---|---|---|---|---|
| Available-for-sale - matures within one year: | ||||
| Corporate bonds | $61,113 | $41 | $(146) | $61,008 |
| Available-for-sale - matures after one year through three years: | ||||
| Corporate bonds | 83,491 | 221 | (1,603) | 82,109 |
| Total | $144,604 | $262 | $(1,749) | $143,117 |
The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of March 31, 2025, and December 31, 2024, and the length of time that those investments have been in a continuous loss position:
| Less than 12 months | 12 months or greater | |||
|---|---|---|---|---|
| Fair value | Gross unrealized loss | Fair value | Gross unrealized loss | |
| As of March 31, 2025 (unaudited) | $24,160 | $(97) | $37,121 | $(1,118) |
| As of December 31, 2024 | $28,762 | $(160) | $61,996 | $(1,589) |
As of March 31, 2025, the allowance for credit losses was not material.
The following table presents gross realized gains and losses from sale of available-for-sale marketable securities:
| Three months ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | (unaudited) | |
| Gross realized gains from sale of available-for-sale marketable securities | $— | $9 |
| Gross realized losses from sale of available-for-sale marketable securities | $— | $(5) |
| NOTE 7: | FAIR VALUE MEASUREMENT |
|---|
FASB ASC No. 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value. Fair value is an exit price, representing the amount that would be received for selling an asset or paid for the transfer of a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value:
| Level I | Unadjusted quoted prices in active markets that are accessible on the measurement date for identical, unrestricted assets or liabilities; |
|---|---|
| Level II | Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and |
| Level III | Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). |
The Company measures its marketable securities, investments in marketable equity securities and foreign currency derivative contracts at fair value. The carrying amount of cash, cash equivalents, short-term bank deposits, trade receivables, other accounts receivable, trade payables and other accounts payables approximate fair value due to the short-term maturity of these instruments. Investments in marketable equity securities are classified within Level I as the securities are traded in an active market. Marketable securities and foreign currency derivative contracts are classified within Level II as the valuation inputs are based on quoted prices and market observable data of similar instruments.
The table below sets forth the Company’s assets and liabilities measured at fair value by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
| Description | March 31, 2025 (unaudited) | Level I (unaudited) | Level II (unaudited) | Level III (unaudited) |
|---|---|---|---|---|
| Assets: | ||||
| Marketable securities: | ||||
| Corporate bonds | $137,481 | $— | $137,481 | $— |
| Investments in marketable equity securities | 258 | 258 | — | — |
| Liabilities: | ||||
| Foreign exchange contracts | 366 | — | 366 | — |
| Description | December 31, 2024 | Level I | Level II | Level III |
|---|---|---|---|---|
| Assets: | ||||
| Marketable securities: | ||||
| Corporate bonds | $143,117 | $— | $143,117 | $— |
| Investments in marketable equity securities | 312 | 312 | — | — |
| NOTE 8: | GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA |
|---|
The Company operates asone operating segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the Company’s chief operating decision maker (“CODM”), which is the Company’s chief executive officer, in deciding how to allocate resources and assess performance. The Company’s CODM evaluates the Company’s financial information and resources and assesses the performance of these resources on a consolidated basis. There is no expense or asset information that are supplemental to those disclosed in these interim condensed consolidated financial statements, that are regularly provided to the CODM. The allocation of resources and assessment of performance of the operating segment is based on consolidated net income as shown in our interim condensed consolidated statements of loss. The CODM considers net income in the annual forecasting process and reviews actual results when making decisions about allocating resources. Since the Company operates as one operating segment, financial segment information, including profit or loss and asset information, can be found in these interim condensed consolidated financial statements.
| a. | Summary information about geographic areas: |
| Three months ended March 31, | ||
|---|---|---|
| 2025 (unaudited) | 2024 (unaudited) | |
| Revenues based on customer location: | ||
| United States | $3,619 | $2,538 |
| Europe and Middle East | 1,484 | 1,512 |
| Asia Pacific (1) | 19,142 | 18,009 |
| Other | — | 13 |
| $24,245 | $22,072 | |
| (1) China | $16,066 | $13,592 |
| March 31, 2025 (unaudited) | December 31, 2024 | |
|---|---|---|
| Long-lived assets by geographic region: | ||
| Israel | $6,095 | $6,788 |
| France | 1,823 | 1,916 |
| United States | 1,646 | 1,716 |
| Greece | 1,037 | 984 |
| Other | 1,258 | 1,284 |
| $11,859 | $12,688 | |
| b. | Major customer data as a percentage of total revenues: |
The following table sets forth the customers that represented 10% or more of the Company’s total revenues in each of the periods set forth below:
| Three months ended March 31, | |||
|---|---|---|---|
| 2025 (unaudited) · 2024 (unaudited) | |||
| Customer A | 24% | 14% | |
| Customer B | * | ) | 15% |
| *) Less than 10% | |||
| c. | Major customer data as a percentage of total trade receivable: |
The following table sets forth the customers that represented 10% or more of the Company’s total trade receivable in each of the periods set forth below:
| March 31, 2025 (unaudited) · 31 December, 2024 | ||||
|---|---|---|---|---|
| Customer A | 28% | 24% | ||
| Customer B | 11% | * | ) | |
| Customer C | * | ) | 12% | |
| *) Less than 10% | ||||
| NOTE 9: | FINANCIAL INCOME, NET |
|---|
| Three months ended March 31, | ||
|---|---|---|
| 2025 (unaudited) | 2024 (unaudited) | |
| Interest income | $1,251 | $1,255 |
| Gain (loss) on available-for-sale marketable securities, net | — | 4 |
| Amortization of discount (premium) on available-for-sale marketable securities, net | 249 | 191 |
| Foreign exchange gain (loss), net | 600 | (193) |
| Total | $2,100 | $1,257 |
| NOTE 10: | NET LOSS PER SHARE OF COMMON STOCK |
|---|
Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during each period, plus dilutive potential shares of common stock considered outstanding during the period, in accordance with FASB ASC No. 260, “Earnings Per Share.”
| Three months ended March 31, | ||
|---|---|---|
| 2025 (unaudited) | 2024 (unaudited) | |
| Numerator: | ||
| Net loss | $(3,327) | $(5,448) |
| Denominator (in thousands): | ||
| Basic and diluted weighted-average common stock outstanding | 23,764 | 23,508 |
| Basic and diluted net loss per share | $(0.14) | $(0.23) |
The total number of shares related to outstanding equity-based awards was 1,843,440 and 1,560,454 for the three months ended March 31, 2025 and 2024, respectively, and in each case was excluded from the calculation of diluted net loss per share.
| NOTE 11: | COMMON STOCK AND STOCK-BASED COMPENSATION PLANS |
|---|
The Company has historically granted a mix of stock options, stock appreciation rights (“SARs”) capped with a ceiling and restricted stock units (“RSUs”) to employees and non‑employee directors of the Company and its subsidiaries under the Company’s equity plans and provides the right to purchase common stock pursuant to the Company’s 2002 employee stock purchase plan to employees of the Company and its subsidiaries. As of March 31, 2025, and December 31, 2024, there wereno outstanding or exercisable SARs left.
The options granted under the Company’s stock incentive plans have been granted at the fair market value of the Company’s common stock on the grant date. Options granted to employees under stock incentive plans generally vest at a rate of 25% of the shares underlying the option after one year and the remaining shares vest in equal portions over the following 36 months, such that all shares are vested after four years. A summary of the Company’s stock option activities and related information for the three months ended March 31, 2025, are as follows:
| Number of options | Weighted average exercise price | Weighted average remaining contractual term | Aggregate intrinsic value | |
|---|---|---|---|---|
| Outstanding as of December 31, 2024 | 84,025 | $22.45 | 2.7 | $765 |
| Granted | — | — | ||
| Exercised | (13,000) | 19.43 | ||
| Forfeited or expired | — | — | ||
| Outstanding as of March 31, 2025 (unaudited) | 71,025 | $23.00 | 2.9 | $228 |
| Exercisable as of March 31, 2025 (unaudited) | 48,689 | $24.07 | 1.6 | $117 |
As of March 31, 2025, there was $216 of unrecognized compensation expense related to unvested stock options. This amount is expected to be recognized over a weighted-average period of 1.9 years.
An RSU award is an agreement to issue shares of the Company’s common stock at the time the award or a portion thereof vests. RSUs granted to employees generally vest inthree equal annual installments starting on thefirst anniversary of the grant date. RSUs granted to non-employee directors, which has historically been granted on or about July 1 of each year, will be made following a director’s election or re-election to the Board at the Company’s annual meeting, and fully vest on thefirst-year anniversary of the grant date instead of over a two-year period.
On February 10, 2025, the Compensation Committee of the Board (the “Committee”) granted 34,612,15,575,13,844 and 13,844 RSUs, effective as of February 14, 2025, to each of the Company’s Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), Chief Operating Officer (“COO”) and Chief Commercial Officer (“CCO”), respectively, pursuant to the Company’s 2011 Stock Incentive Plan (the “2011 Plan”). The RSU awards vest 33.4% on February 14, 2026,33.3% on February 14, 2027 and 33.3% on February 14, 2028.
Also, on February 10, 2025, the Committee granted 51,918,10,383,9,229 and 9,229 performance-based stock units (“PSUs”), effective as of February 14, 2025, to each of the Company’s CEO, CFO, COO and CCO, respectively, pursuant to the 2011 Plan. The performance goals for the PSUs with specified weighting are as follows:
| Weighting | Goals |
| 50% | Vesting of the full 50% of the PSUs occurs if the Company achieves the 2025 license and related revenue target approved by the Board (the “2025 License Revenue Target”). The vesting threshold is achievement of 90% of the 2025 License Revenue Target. If the Company’s achievement of the 2025 License Revenue Target is above 90% but less than 99% of the 2025 License Revenue Target, 91% to 99% of the eligible PSUs would be subject to vesting. If the Company’s actual result exceeds 100% of the 2025 License Revenue Target, every 1% increase of the 2025 License Revenue Target, up to 110%, would result in an increase of 7% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 10% of the eligible PSUs for the Company’s CEO. |
| 25% | Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2025 is greater than the S&P Semiconductors Select Industry index (the “S&P index”). The vesting threshold is if the return on the Company’s stock for 2025 is at least 90% of the S&P index. If the return on the Company’s stock, in comparison to the S&P index, is above 90% but less than 99% of the S&P index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the S&P index, every 1% increase in comparison to the S&P index, up to 110%, would result in an increase of 7% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 10% of the eligible PSUs for the Company’s CEO. |
| 25% | Vesting of the full 25% of the PSUs occurs if the Company achieves positive total shareholder return whereby the return on the Company’s stock for 2025 is greater than the Russell 2000 index (the “Russell index”). The vesting threshold is if the return on the Company’s stock for 2025 is at least 90% of the Russell index. If the return on the Company’s stock, in comparison to the Russell index, is above 90% but less than 99% of the Russell index, 91% to 99% of the eligible PSUs would be subject to vesting. If the return on the Company’s stock exceeds 100% of the Russell index, every 1% increase in comparison to the Russell index, up to 110%, would result in an increase of 7% of the eligible PSUs for the Company’s CFO, COO and CCO and an increase of 10% of the eligible PSUs for the Company’s CEO. |
Accordingly, assuming maximum achievement of the performance goals set forth above, PSUs representing an additional 100%, meaning an additional 51,918, would be eligible for vesting of the Company’s CEO, and an additional 70%, meaning an additional 7,268,6,460 and 6,460, would be eligible for vesting for each of the Company’s CFO, COO and CCO, respectively.
Subject to achievement of the thresholds the above performance goals for 2025, the PSUs vest 33.4% on February 14, 2026,33.3% on February 14, 2027, and 33.3% on February 14, 2028.
A summary of the Company’s RSU and PSU activities and related information for the three months ended March 31, 2025, are as follows:
| Number of RSUs and PSUs | Weighted Average Grant- Date Fair Value | |
|---|---|---|
| Unvested as of December 31, 2024 | 1,603,508 | $21.01 |
| Granted | 426,957 | 25.56 |
| Vested | (213,628) | 26.92 |
| Forfeited or expired | (44,422) | 17.63 |
| Unvested as of March 31, 2025 (unaudited) | 1,772,415 | $22.83 |
As of March 31, 2025, there was $27,392 of unrecognized compensation expense related to unvested RSUs and PSUs. This amount is expected to be recognized over a weighted-average period of 1.6 years.
The following table shows the total equity-based compensation expense included in the interim condensed consolidated statements of loss:
| Three months ended March 31, | ||
|---|---|---|
| 2025 (unaudited) | 2024 (unaudited) | |
| Cost of revenue | $159 | $203 |
| Research and development, net | 2,466 | 2,007 |
| Sales and marketing | 566 | 365 |
| General and administrative | 1,132 | 996 |
| Total equity-based compensation expense | $4,323 | $3,571 |
The fair value for rights to purchase shares of common stock under the Company’s employee stock purchase plan was estimated on the date of grant using the following assumptions:
| 2025 (unaudited) · 2024 (unaudited) | ||||
|---|---|---|---|---|
| Expected dividend yield | 0% | 0% | ||
| Expected volatility | 41% | - | 48% | 46% |
| Risk-free interest rate | 4.2% | - | 4.4% | 5.3% |
| Contractual term of up to (months) | 6 | 6 | ||
| NOTE 12: | DERIVATIVES AND HEDGING ACTIVITIES |
|---|
The Company follows the requirements of FASB ASC No. 815,” Derivatives and Hedging” which requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging transaction and further, on the type of hedging transaction. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. Due to the Company’s global operations, it is exposed to foreign currency exchange rate fluctuations in the normal course of its business. The Company’s treasury policy allows it to offset the risks associated with the effects of certain foreign currency exposures through the purchase of foreign exchange forward or option contracts (“Hedging Contracts”). The policy, however, prohibits the Company from speculating on such Hedging Contracts for profit. To protect against the increase in value of forecasted foreign currency cash flow resulting from salaries paid in currencies other than the U.S. dollar during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll of its non-U.S. employees denominated in the currencies other than the U.S. dollar for a period of one to twelve months with Hedging Contracts. Accordingly, when the dollar strengthens against the foreign currencies, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the Hedging Contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency expenses is offset by gains in the fair value of the Hedging Contracts. These Hedging Contracts are designated as cash flow hedges.
For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of March 31, 2025, the notional principal amount of the Hedging Contracts to sell U.S. dollars held by the Company was $16,950. There were no open Hedging Contracts as of December 31, 2024.
The fair value of the Company’s outstanding derivative instruments is as follows:
| March 31, 2025 (unaudited) | December 31, 2024 | |
|---|---|---|
| Derivative liabilities: | ||
| Derivatives designated as cash flow hedging instruments: | ||
| Foreign exchange option contracts | $96 | $— |
| Foreign exchange forward contracts | 270 | — |
| Total | $366 | $— |
The increase (decrease) in unrealized gains (losses) recognized in “accumulated other comprehensive gain (loss)” on derivatives, before tax effect, is as follows:
| Three months ended March 31, | ||
|---|---|---|
| 2025 (unaudited) | 2024 (unaudited) | |
| Derivatives designated as cash flow hedging instruments: | ||
| Foreign exchange option contracts | $(96) | $— |
| Foreign exchange forward contracts | (190) | (195) |
| $(286) | $(195) | |
The net (gains) losses reclassified from “accumulated other comprehensive gain (loss)” into income are as follows:
| Three months ended March 31, | ||
|---|---|---|
| 2025 (unaudited) | 2024 (unaudited) | |
| Derivatives designated as cash flow hedging instruments: | ||
| Foreign exchange option contracts | $— | $— |
| Foreign exchange forward contracts | (80) | (380) |
| $(80) | $(380) | |
The Company recorded in cost of revenues and operating expenses a net gain of $80 and $380 during the three months ended March 31, 2025 and 2024, respectively, related to its Hedging Contracts.
| NOTE 13: | ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) |
|---|
The following tables summarize the changes in accumulated balances of other comprehensive income (loss), net of taxes:
| Three months ended March 31, 2025 (unaudited) | Three months ended March 31, 2024 (unaudited) | |||||
|---|---|---|---|---|---|---|
| Unrealized gains (losses) on available-for- sale marketable securities | Unrealized gains (losses) on cash flow hedges | Total | Unrealized gains (losses) on available-for- sale marketable securities | Unrealized gains (losses) on cash flow hedges | Total | |
| Beginning balance | $(1,330) | $— | $(1,330) | $(3,317) | $988 | $(2,329) |
| Other comprehensive income (loss) before reclassifications | 588 | (286) | 302 | 188 | (195) | (7) |
| Amounts reclassified from accumulated other comprehensive income (loss) | — | (80) | (80) | (4) | (380) | (384) |
| Net current period other comprehensive income (loss) | 588 | (366) | 222 | 184 | (575) | (391) |
| Ending balance | $(742) | $(366) | $(1,108) | $(3,133) | $413 | $(2,720) |
The following table provides details about reclassifications out of accumulated other comprehensive income (loss):
| Details about Accumulated Other Comprehensive Income (Loss) Components · Amount Reclassified from Accumulated Other Comprehensive Income (Loss) · Affected Line Item in the Statements of Income (Loss) | |||
|---|---|---|---|
| Three months ended March 31, | |||
| 2025 (unaudited) · 2024 (unaudited) | |||
| Unrealized gains (losses) on cash flow hedges | $2 | $8 | Cost of revenues |
| 67 | 324 | Research and development | |
| 3 | 9 | Sales and marketing | |
| 8 | 39 | General and administrative | |
| 80 | 380 | Total, before income taxes | |
| — | — | Income tax expense (benefit) | |
| 80 | 380 | Total, net of income taxes | |
| Unrealized gains (losses) on available-for-sale marketable securities | — | 4 | Financial income (loss), net |
| — | — | Income tax benefit | |
| — | 4 | Total, net of income taxes | |
| $80 | $384 | Total, net of income taxes | |
| NOTE 14: | SHARE REPURCHASE PROGRAM |
|---|
The Company didnot repurchase any shares of common stock during the first quarter of 2025. During the three months ended March 31, 2024, the Company repurchased 56,872 shares of common stock at an average purchase price of $22.48 per share for an aggregate purchase price of $1,278. As of March 31, 2025,1,024,781 shares of common stock remained available for repurchase pursuant to the Company’s share repurchase program.
The repurchases of common stock are accounted for as treasury stock, and result in a reduction of stockholders’ equity. When treasury shares are reissued, the Company accounts for the reissuance in accordance with FASB ASC No. 505-30, “Treasury Stock” and charges the excess of the repurchase cost over issuance price using the weighted average method to retained earnings. The purchase cost is calculated based on the specific identification method. In the case where the repurchase cost over issuance price using the weighted average method is lower than the issuance price, the Company credits the difference to additional paid-in capital.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.